Modus Therapeutics Holding AB Total Liabilities

Latest as of December 2025: Skr3.62 Million SEK ≈ $389.03K USD

Modus Therapeutics Holding AB total liabilities. Based on the latest financial reports, Modus Therapeutics Holding AB (MODTX) has total liabilities worth Skr3.62 Million SEK (≈ $389.03K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See defensive interval ratio of Modus Therapeutics Holding AB to measure how many days the company can operate on defensive assets alone.

Total Liabilities of Modus Therapeutics Holding AB (2018–2025)

Total liabilities of Modus Therapeutics Holding AB from 2018 to 2025. This chart illustrates how Modus Therapeutics Holding AB's total liabilities have evolved over time, based on quarterly financial data.

Modus Therapeutics Holding AB Competitors by Total Liabilities

The table below lists competitors of Modus Therapeutics Holding AB ranked by their total liabilities.

Company	Country	Total Liabilities
New Zealand Coastal Seafoods Ltd AU:NZS	Australia	AU$2.94 Million
Connexa Sports Technologies Inc. NASDAQ:YYAI	USA	$85.67 Million
Clear Blue Technologies International Inc V:CBLU	Canada	CA$11.52 Million
Noram Lithium Corp V:NRM	Canada	CA$420.55K
Mobico Group Plc LSE:MCG	UK	GBX3.07 Billion
CCH Holdings Ltd Ordinary Shares NASDAQ:CCHH	USA	$7.60 Million
Wellnex Life Ltd AU:WNX	Australia	AU$16.59 Million
Churchill Resources Inc V:CRI	Canada	CA$1.26 Million

Liability Composition Analysis (2018–2025)

This chart breaks down Modus Therapeutics Holding AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see MODTX current and non-current assets.

Liquidity & Leverage Metrics

Modus Therapeutics Holding AB Total Liabilities Ratios Explained

Modus Therapeutics Holding AB total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	3.51	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.40	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.28	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Modus Therapeutics Holding AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Modus Therapeutics Holding AB (2018–2025)

The table below shows the annual total liabilities of Modus Therapeutics Holding AB from 2018 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr3.62 Million ≈ $389.03K	+31.60%
2024-12-31	Skr2.75 Million ≈ $295.62K	+16.45%
2023-12-31	Skr2.36 Million ≈ $253.87K	-82.97%
2022-12-31	Skr13.86 Million ≈ $1.49 Million	+153.96%
2021-12-31	Skr5.46 Million ≈ $587.15K	+1000.00%
2020-12-31	Skr496.00K ≈ $53.38K	-89.53%
2019-12-31	Skr4.74 Million ≈ $509.78K	-79.45%
2018-12-31	Skr23.05 Million ≈ $2.48 Million	--

About Modus Therapeutics Holding AB

ST:MODTX Sweden Biotechnology

Market Cap

$3.27 Million

Skr30.41 Million SEK

Market Cap Rank

#29312 Global

#661 in Sweden

Share Price

Skr0.17

Change (1 day)

+6.13%

52-Week Range

Skr0.16 - Skr0.50

All Time High

Skr6.80